Emoxypine
Antioxidant medicine (Mexidol) used for stroke and brain blood-vessel disease in Russia; not approved in the EU or the US.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
Pharmacology
Contents
DETAILED OVERVIEW
What is Emoxypine?
Emoxypine is a compound with antioxidant action. Its version sold as Mexidol is approved as a prescription medicine in Russia and several neighboring countries, mainly for diseases of the brain's blood vessels and for stroke. It is not approved in the European Union, the United Kingdom or the United States, and regulators there have not evaluated it.
It limits the damage that free radicals do to the fats in cell membranes, supports the cells' energy production when oxygen is short, and also affects one of the brain's calming signaling systems (GABA). In placebo-controlled trials in Russia and neighboring countries, recovery improved in the early phase of stroke, but it has no Western approval or evaluation. Mild drowsiness, nausea and dry mouth can occur. It is contraindicated in acute liver or kidney failure, and its safety in pregnancy and breastfeeding is not established.
Mechanism
Antioxidant + membrane stabilizer + GABA-A modulation
Evidence
Russian/CIS human RCTs (stroke); no Western validation
Legal status
Prescription drug in Russia/CIS; not FDA/EMA
No anecdote collected yet.
Receptor profile
- Free-radical oxidation / lipid peroxidationStrong
- Antioxidant enzymes (SOD, glutathione peroxidase)Moderate
- GABA-A / benzodiazepine receptor complexModerate
- Cerebral blood flow / mitochondrial ATP productionModerate
Safety
Side effects, stop signs, contraindications
Side effects · 5
- Mild drowsiness or sedation, especially at higher doses
- Nausea, dry mouth or mild stomach upset
- Transient metallic taste, throat irritation or warmth on intravenous administration
- Rarely, allergic skin reaction (rash, itching)
- Most human safety data come from Russian/CIS clinical trials; Western regulatory review is lacking
Contraindications · 4
- Acute liver or kidney failure
- Pregnancy and breastfeeding: safety not sufficiently established, avoid
- Known hypersensitivity to pyridine derivatives or to succinate
- Caution with CNS depressants (additive sedation possible)
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
Results of a randomized double blind multicenter placebo-controlled trial of mexidol efficacy and safety in hemispheric ischemic stroke (EPICA)
Skvortsova VI, Stakhovskaya LV, Narbut AI, et al.
Results of the international multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of the sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (MIR)
Stakhovskaya LV, et al.
Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke
Fedin AI, Zakharov VV, Tanashyan MM, et al.
Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of stroke
Fedin AI, et al.
The known and new ideas about the mechanism of action and the spectrum of effects of Mexidol
Voronina TA, et al.
FAQ
FAQ
Emoxypine is an antioxidant compound marketed as an approved medicine (Mexidol) in Russia and neighboring countries, used mainly for brain circulation problems and stroke recovery. Clinical studies suggest it can support neurological recovery and daily functioning during the acute and early recovery phases of stroke, and it's also reported to help reduce anxiety. As an antioxidant it protects cells from damage, and it's also used in chronic cerebrovascular disease to support cognition and circulation.
Telegram
Have a question about Emoxypine?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.
